179 related articles for article (PubMed ID: 32823610)
21. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
Wykosky J; Gibo DM; Stanton C; Debinski W
Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
[TBL] [Abstract][Full Text] [Related]
22. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction.
Tan SM; Zhang Y; Connelly KA; Gilbert RE; Kelly DJ
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1415-25. PubMed ID: 20154262
[TBL] [Abstract][Full Text] [Related]
23. The Expression of ephrinA1/ephA2 Receptor Increases in Chronic Rhinosinusitis and ephrinA1/ephA2 Signaling Affects Rhinovirus-Induced Innate Immunity in Human Sinonasal Epithelial Cells.
Lee SH; Kang SH; Han MS; Kwak JW; Kim HG; Lee TH; Lee DB; Kim TH
Front Immunol; 2021; 12():793517. PubMed ID: 34975898
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
25. Anatomical-Molecular Distribution of EphrinA1 in Infarcted Mouse Heart Using MALDI Mass Spectrometry Imaging.
Lefcoski S; Kew K; Reece S; Torres MJ; Parks J; Reece S; de Castro Brás LE; Virag JAI
J Am Soc Mass Spectrom; 2018 Mar; 29(3):527-534. PubMed ID: 29305797
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury.
Hong JY; Shin MH; Douglas IS; Chung KS; Kim EY; Jung JY; Kang YA; Kim SK; Chang J; Kim YS; Park MS
Clin Sci (Lond); 2016 Nov; 130(21):1993-2003. PubMed ID: 27549114
[TBL] [Abstract][Full Text] [Related]
27. Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.
Gurantz D; Yndestad A; Halvorsen B; Lunde OV; Omens JH; Ueland T; Aukrust P; Moore CD; Kjekshus J; Greenberg BH
Cardiovasc Res; 2005 Jul; 67(1):106-15. PubMed ID: 15949474
[TBL] [Abstract][Full Text] [Related]
28. Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level.
Mo J; Zhao X; Dong X; Liu T; Zhao N; Zhang D; Wang W; Zhang Y; Sun B
Cell Oncol (Dordr); 2020 Aug; 43(4):655-667. PubMed ID: 32291572
[TBL] [Abstract][Full Text] [Related]
29. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
Su J; Ji XB; Xie JH; Li W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):929-936. PubMed ID: 27978884
[No Abstract] [Full Text] [Related]
30. Erythropoietin-Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury.
Park BH; Shin MH; Douglas IS; Chung KS; Song JH; Kim SY; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):519-529. PubMed ID: 29216437
[TBL] [Abstract][Full Text] [Related]
31. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
32. EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis.
Funk SD; Yurdagul A; Albert P; Traylor JG; Jin L; Chen J; Orr AW
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):686-95. PubMed ID: 22247258
[TBL] [Abstract][Full Text] [Related]
33. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
Wykosky J; Palma E; Gibo DM; Ringler S; Turner CP; Debinski W
Oncogene; 2008 Dec; 27(58):7260-73. PubMed ID: 18794797
[TBL] [Abstract][Full Text] [Related]
34. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202
[TBL] [Abstract][Full Text] [Related]
35. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
36. Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction.
Ju CH; Wang XP; Gao CY; Zhang SX; Ma XH; Liu C
Cell Physiol Biochem; 2015; 36(4):1305-15. PubMed ID: 26160442
[TBL] [Abstract][Full Text] [Related]
37. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
[TBL] [Abstract][Full Text] [Related]
38. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
Noblitt LW; Bangari DS; Shukla S; Knapp DW; Mohammed S; Kinch MS; Mittal SK
Cancer Gene Ther; 2004 Nov; 11(11):757-66. PubMed ID: 15359289
[TBL] [Abstract][Full Text] [Related]
39. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.
Ghali R; Habeichi NJ; Kaplan A; Tannous C; Abidi E; Bekdash A; Farhat R; Itani H; Jurjus A; Booz GW; Mallat Z; Zouein FA
Clin Sci (Lond); 2020 Jun; 134(11):1191-1218. PubMed ID: 32432676
[TBL] [Abstract][Full Text] [Related]
40. Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis.
Vilahur G; Casaní L; Peña E; Crespo J; Juan-Babot O; Ben-Aicha S; Mendieta G; Béjar MT; Borrell M; Badimon L
Int J Cardiol; 2018 Nov; 270():28-35. PubMed ID: 29936043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
